Disappearance of cryoproteins in the sera of a patient with SLE after treatment with blisibimod, a novel subcutaneous anti-B cell therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Rheumatology (Oxford, England) England), 2014-05, Vol.53 (5), p.957-958
Hauptverfasser:	Golmia, Andrea Pimentel Fonseca, Martin, Renee, Hislop, Colin, Scheinberg, Morton
Format:	Artikel
Sprache:	eng
Schlagworte:	B-Cell Activating Factor - drug effects B-Lymphocytes - drug effects B-Lymphocytes - pathology Cell Proliferation - drug effects Cryoglobulins - metabolism Female Humans Injections, Subcutaneous Lupus Erythematosus, Systemic - blood Lupus Erythematosus, Systemic - drug therapy Recombinant Fusion Proteins - administration & dosage Recombinant Fusion Proteins - pharmacology Recombinant Fusion Proteins - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!